Antioxidants in the chemoprevention of colorectal cancer and colorectal adenomas in the general population: A systematic review and meta-analysis

Colorectal Disease

Volumn 13, Issue 10, 2011, Pages 1085-1099

  Papaioannou, Diana ^a   Cooper, K L ^a   Carroll, C ^a   Hind, D ^a   Squires, H ^a   Tappenden, P ^a   Logan, R F ^b  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Chemoprevention; Colorectal cancer; Meta analysis; Systematic review

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASBESTOS; ASCORBIC ACID; BETA CAROTENE; PLACEBO; RETINOL; SELENIUM;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ALOPECIA; BRAIN HEMORRHAGE; CANCER RISK; CARDIOVASCULAR RISK; CHEMOPROPHYLAXIS; CINAHL; COCHRANE LIBRARY; COLORECTAL ADENOMA; COLORECTAL CANCER; DATA EXTRACTION; DERMATITIS; DRUG EFFICACY; DRUG SAFETY; EMBASE; EPISTAXIS; HUMAN; HYPERCAROTENEMIA; JAUNDICE; MEDICAL LITERATURE; MEDLINE; META ANALYSIS; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROCTOCOLECTOMY; QUALITATIVE ANALYSIS; REVIEW; SMOKING; SYSTEMATIC REVIEW;

ADENOMA; ANTIOXIDANTS; ASCORBIC ACID; BETA CAROTENE; COLORECTAL NEOPLASMS; HUMANS; SELENIUM; VITAMIN A; VITAMIN E;

EID: 80053054596     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/j.1463-1318.2010.02289.x     Document Type: Review

References (43)

1. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007; 18: 581-92.
2. National Institute for Health and Clinical Excellence (NICE). (2004) Guidance on Cancer Services: Improving Outcomes in Colorectal Cancers (Manual Update). London: NICE.
3. Muto T, Bussey HJ, Morson BC. The evolution of cancer of the colon and rectum. Cancer 1975; 36: 2251-70.
4. Hoff G, Vatn MH. Colonic adenoma: natural history. Dig Dis 1991; 9: 61-9.
5. Atkin WS, Saunders BP. Surveillance guidelines after removal of colorectal adenomatous polyps. Gut 2002; 51(Suppl. 5): V6-9.
6. Stryker SJ, Wolff BG, Culp CE, Libbe SD, Ilstrup DM, MacCarty RL. Natural history of untreated colonic polyps. Gastroenterology 1987; 93: 1009-13.
7. Dubé C, Rostom A, Lewin G et al. The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force.[see comment][summary for patients in Ann Intern Med. 2007 Mar 6;146(5):I35; PMID: 17339615]. Ann Intern Med 2007; 146: 365-75.
8. Rostom A, Dube C, Lewin G et al. Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force. [see comment][summary for patients in Ann Intern Med. 2007 Mar 6;146(5):I35; PMID: 17339615]. Ann Intern Med 2007; 146: 376-89.
9. Weingarten MA, Zalmanovici A, Yaphe J. Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps. [update of Cochrane Database Syst Rev. 2005;(3):CD003548; PMID: 16034903]. Cochrane Database Syst Rev 2008;(1):CD003548.
10. Shaukat A, Scouras N, Schunemann HJ. Role of supplemental calcium in the recurrence of colorectal adenomas: a metaanalysis of randomized controlled trials. [see comment]. Am J Gastroenterol 2005; 100: 390-4.
11. Lonn E. Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 2006; 354: 1567-77.
12. Zhang SM, Cook NR, Albert CM, Gaziano JM, Buring JE, Manson JE. Effect of combined folic acid, vitamin B6, and vitamin B12 on cancer risk in women: a randomized trial. JAMA 2008; 300: 2012-21.
13. Zhu S, Mason J, Shi Y et al. The effect of folic acid on the development of stomach and other gastrointestinal cancers. Chin Med J 2003; 116: 15-9.
14. Carroll C, Cooper K, Papaioannou D et al. Meta-analysis: folic acid in the prevention of colorectal adenomas and the chemoprevention of colorectal cancer. Aliment Pharmacol Ther 2010; 31: 708-18.
15. Bjelakovic G, Nagorni A, Nikolova D, Simonetti RG, Bjelakovic M, Gluud C. Meta-analysis: antioxidant supplements for primary and secondary prevention of colorectal adenoma. Aliment Pharmacol Ther 2006; 24: 281-91.
16. Maxwell SR. Antioxidant vitamin supplements: update of their potential benefits and possible risks. Drug Saf 1999; 21: 253-66.
17. Sporn MB, Suh N. Chemoprevention of cancer. Carcinogenesis 2000; 21: 525-30.
18. Diplock AT. Antioxidants and disease prevention. Mol Aspects Med 1994; 15: 293-376.
19. Bjelakovic G, Nikolova D, Simonetti RG, Gluud C. Antioxidant supplements for preventing gastrointestinal cancers. Cochrane Database Syst Rev 2008; 4: CD004183.
20. Lin J, Cook NR, Albert C et al. Vitamins C and E and beta carotene supplementation and cancer risk: a randomized controlled trial. J Natl Cancer Inst 2009; 101: 14-23.
21. Gaziano JM, Glynn RJ, Christen WG et al. Vitamins E and C in the prevention of prostate and total cancer in men: the Physicians' Health Study II randomized controlled trial. JAMA 2009; 301: 52-62.
22. Lippman SM, Klein EA, Goodman PJ et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2009; 301: 39-51.
23. Scottish Intercollegiate Guidelines Network. Search filters: randomised controlled trials. Available at:.
24. Cooper K, Pilgrim H, Carroll C et al. Chemoprevention of colorectal cancer: systematic review and economic model. Health Technol Assess 2010; (in press).
25. NHS CRD. (2009) NHS Centre for Reviews and Dissemination. Report 4: Undertaking Systematic Reviews of Research on Effectiveness; CRD's Guidance for those Carrying out or Commissioning Reviews. University of York, York.
26. Review Manager (RevMan). [Computer Program] Version 5.0. The Nordic Cochrane Centre, The Cochrane Collaboration, Copenhagen, 2008.
27. Goodman GE, Thornquist MD, Balmes J et al. The Beta-Carotene and Retinol Efficacy Trial: incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping β-carotene and retinol supplements. J Natl Cancer Inst 2004; 96: 1743-50.
28. Lee IM, Cook NR, Gaziano JM et al. Vitamin E in the primary prevention of cardiovascular disease and cancer. The women's health study: a randomized controlled trial. J Am Med Assoc 2005; 294: 56-65.
29. Lee IM, Cook NR, Manson JE, Buring JE, Hennekens CH. Beta-carotene supplementation and incidence of cancer and cardiovascular disease: the Women's Health Study. J Natl Cancer Inst 1999; 91: 2102.
30. Duffield-Lillico AJ, Reid ME, Turnbull BW et al. Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer Trial. Cancer Epidemiol Biomarkers Prev 2002; 11: 630-9.
31. Hennekens CH, Buring JE, Manson JE et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996; 334: 1145-9.
32. Lonn E, Bosch J, Yusuf S et al. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA 2005; 293: 1338-47.
33. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20, 536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002; 360: 7-22.
34. Hercberg S, Galan P, Preziosi P, Bertrais S, Mennen L, Malvy D. The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch Intern Med 2004; 164: 2335-42.
35. Malila N, Virtamo J, Virtanen M, Albanes D, Tangrea JA, Huttunen JK. The effect of α-tocopherol and β-carotene supplementation on colorectal adenomas in middle-aged male smokers. Cancer Epidemiol Biomarkers Prev 1999; 8: 489-93.
36. Virtamo J, Pietinen P, Huttunen JK et al. Incidence of cancer and mortality following α-tocopherol and β-carotene supplementation: a postintervention follow-up. JAMA 2003; 290: 476-85.
37. Reid ME, Duffield-Lillico AJ, Sunga A et al. Selenium supplementation and colorectal adenomas: an analysis of the nutritional prevention of cancer trial. Int J Cancer 2006; 118: 1777-81.
38. Daya S. Funnel plots and publication bias-work in progress? Evidence-based Obstet and Gynecol 2006; 8: 71-2.
39. Higgins JPT, Green S (eds). (2008) Cochrane Handbook for Systematic Reviews of Interventions. Version 5.0.1 (updated September 2008). Cochrane Collaboration, Oxford.
40. Winawer SJ, Zauber AG, Ho MN et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 1993; 329: 1977-81.
41. Flossmann E, Rothwell PM, British Doctors Aspirin Trial and the UK-TIA Aspirin Trial. Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies. [see comment]. Lancet 2007; 369:1603-13.
42. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst Rev 2008; 2: CD007176.
43. Albanes D. Vitamin supplements and cancer prevention: where do randomized controlled trials stand? J Natl Cancer Inst 2009; 101: 2-4.